Cytosorbents
CTSO
#10490
Rank
โ‚ฌ21.68 M
Marketcap
0,35ย โ‚ฌ
Share price
3.55%
Change (1 day)
-61.05%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚ฌ10.51 Million

According to Cytosorbents's latest financial reports the company's current earnings are โ‚ฌ37.2 Million. In 2025 the company made an earning of -โ‚ฌ7.55 Million, an increase over its 2024 earnings that were of -โ‚ฌ19.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ10.51 Million39.27%
2025 -โ‚ฌ7.55 Million-62.16%
2024 -โ‚ฌ19.93 Million-22.49%
2023 -โ‚ฌ25.71 Million-13.52%
2022 -โ‚ฌ29.73 Million34.04%
2021 -โ‚ฌ22.18 Million182.17%
2020 -โ‚ฌ7.86 Million-55.97%
2019 -โ‚ฌ17.85 Million14.17%
2018 -โ‚ฌ15.64 Million95.14%
2017 -โ‚ฌ8.02 Million-22.32%
2016 -โ‚ฌ10.32 Million39.1%
2015 -โ‚ฌ7.42 Million-12.89%
2014 -โ‚ฌ8.52 Million89%
2013 -โ‚ฌ4.51 Million26.65%
2012 -โ‚ฌ3.56 Million-26.02%
2011 -โ‚ฌ4.81 Million-288.45%
2010 โ‚ฌ2.55 M-4.17%
2009 โ‚ฌ2.66 M-287.19%
2008 -โ‚ฌ1.43 Million-47.12%
2007 -โ‚ฌ2.69 Million41.78%
2006 -โ‚ฌ1.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚ฌ3.28 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ0.68 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚ฌ48.66 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA